封面
市場調查報告書
商品編碼
1577298

腸內飼管市場、機會、成長動力、產業趨勢分析與預測,2024-2032

Enteral Feeding Tubes Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

受腸內餵食技術進步、慢性病患病率上升、人口老化、早產率上升以及家庭醫療保健採用趨勢不斷成長的推動,2024年至2032年全球腸內飼管市場將成長6.3%,除其他因素外。

推動腸內飼管產業成長的因素包括技術進步、人口老化和慢性病的增加。隨著醫療保健技術的發展,腸內餵食方法變得更加高效和方便用戶使用,從而導致越來越多的採用。全球慢性病的增加,尤其是人口老化,需要營養支持,進一步推動市場成長。此外,早產的激增和家庭醫療保健採用的成長趨勢凸顯了對腸內餵食解決方案的需求不斷擴大。

腸飼管市場根據產品、疾病狀況、病人、管類型、管放置、最終用途和地區進行分類。

市場將產品分為鼻腸/鼻飼管和腹部/造口飼管。鼻腸/鼻飼管段包括鼻胃管和鼻空腸管,而腹部/造口段包括胃造口管、空腸造口/空腸管和胃空腸管(GJ)或經空腸管。鼻腸/鼻飼管領域在 2023 年以 17 億美元的收入引領市場。這使它們成為各種臨床情況下臨時營養支持的理想選擇。此外,加護病房 (ICU) 中的患者通常無法口服進食,因此越來越依賴鼻腸飼管。這一趨勢是由重症疾病和手術導致的 ICU 入院率上升所推動的,凸顯了該細分市場的成長。

市場根據疾病狀況對腸內飼管進行分類,包括癌症、中樞神經系統 (CNS) 和心理健康問題、非惡性胃腸道 (GI) 疾病等。癌症細分市場進一步分為頭頸癌、胃腸道癌和其他癌症,到2023 年將佔48% 的腸內飼管市場佔有率。 。隨著癌症治療的進步提高了存活率,對長期營養支持的需求激增,推動了該領域的成長。

2023年北美腸內飼管市場規模達8.762億美元,預計2024年至2032年複合年成長率為5.9%。 。改進的飼管設計和高效的飼管等創新提高了採用率。此外,經常面臨先天畸形和嚴重疾病的兒科患者對腸內餵食的需求更高。這種針對弱勢兒科族群的特殊營養需求進一步推動了區域市場的成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 全球癌症病例數增加
      • 早產和兒科疾病發生率上升
      • 中樞神經系統發育和心理健康障礙
      • 增加代謝紊亂
      • 最近的技術進步
      • 家庭醫療保健採用率上升
    • 產業陷阱與挑戰
      • 發展中和低度開發地區缺乏認知
      • 與腸內餵食相關的風險
  • 成長潛力分析
  • 監管環境
  • 差距分析
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2021 - 2032 年

  • 主要趨勢
  • 鼻腸/鼻飼管
    • 鼻胃管
    • 鼻空腸管
  • 腹部/造口飼管
    • 胃造口管
    • 空腸造口/空腸管
    • 胃空腸 (GJ) 或經空腸管

第 6 章:市場估計與預測:按疾病狀況,2021 - 2032 年

  • 主要趨勢
  • 癌症
    • 頭頸癌
    • 胃腸癌
    • 其他癌症
  • 中樞神經系統(CNS)和心理健康
  • 非惡性胃腸道 (GI) 疾病
  • 其他疾病狀況

第 7 章:市場估計與預測:按患者分類,2021 - 2032 年

  • 主要趨勢
  • 成人
  • 兒科

第 8 章:市場估計與預測:按管類型,2021 - 2032

  • 主要趨勢
  • 短期飼管
  • 長期飼管
  • 臨時飼管

第 9 章:市場估計與預測:按管佈置,2021 - 2032 年

  • 主要趨勢
  • 無需手術
  • 手術放置
  • 內視鏡放置

第 10 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 居家護理
  • 醫院
  • 其他最終用戶

第 11 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 12 章:公司簡介

  • Abbott Laboratories
  • Applied Medical Technology, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • Cardinal Health
  • CONMED Corporation
  • Cook Medical
  • Danone SA
  • Fresenius Kabi AG
  • Medline Industries, Inc.
  • MOOG Inc.
  • Vygon
簡介目錄
Product Code: 4846

The Global Enteral Feeding Tubes Market will witness a 6.3% from 2024 to 2032, driven by advancements in enteral feeding technology, a rising prevalence of chronic diseases, an aging population, an uptick in preterm births, and a growing trend towards home healthcare adoption, among other factors.

Factors driving the growth of the enteral feeding tubes industry include technological advancements, an aging population, and a rise in chronic diseases. As healthcare technology evolves, enteral feeding methods become more efficient and user-friendly, leading to increased adoption. The global rise in chronic diseases, especially in aging populations, necessitates nutritional support, further propelling market growth. Additionally, the surge in preterm births and the growing trend of home healthcare adoption underscore the expanding demand for enteral feeding solutions.

The Enteral Feeding Tubes Market is categorized based on product, disease condition, patient, tube type, tube placement, end use , and region.

The market categorizes products into nasoenteric/nasal feeding tubes and abdominal/ostomy feeding tubes. The nasoenteric/nasal feeding tube segment includes nasogastric and nasojejunal tubes, while the abdominal/ostomy segment encompasses gastrostomy, jejunostomy/jejunal, and gastrojejunal (GJ) or transjejunal tubes. The nasoenteric/nasal feeding tube segment led the market with a revenue of USD 1.7 billion in 2023. Nasoenteric tubes, favored for short-term feeding (typically under four weeks), are less invasive than other methods. This makes them ideal for temporary nutritional support across various clinical scenarios. Moreover, patients in intensive care units (ICUs), often unable to eat orally, increasingly rely on nasoenteric feeding tubes. This trend, driven by rising ICU admissions from critical illnesses and surgeries, underscores the segment's growth.

The market classifies enteral feeding tubes based on disease conditions, including cancer, central nervous system (CNS) & mental health issues, non-malignant gastrointestinal (GI) disorders, and others. The cancer segment, further divided into head and neck, gastrointestinal, and other cancers, commanded a 48% enteral feeding tubes market share in 2023. Treatments like chemotherapy and radiation can induce side effects such as nausea and difficulty swallowing. With advancements in cancer treatments boosting survival rates, the demand for long-term nutritional support has surged, propelling the segment's growth.

North America enteral feeding tubes market accounted for USD 876.2 million in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2032. As a frontrunner in healthcare innovation, North America has been pivotal in advancing enteral feeding technologies. Innovations, including enhanced feeding tube designs and efficient feeding pumps, have spurred adoption rates. Additionally, pediatric patients, often facing congenital abnormalities and severe illnesses, have a heightened need for enteral feeding. This specialized nutritional demand for vulnerable pediatric populations has further fueled the regional market growth.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increase in number of cancer cases across the globe
      • 3.2.1.2 Rise in incidence of premature births and pediatric diseases
      • 3.2.1.3 Growing central nervous system and mental health disorders
      • 3.2.1.4 Increasing metabolic disorders
      • 3.2.1.5 Recent technological advancements
      • 3.2.1.6 Rise in adoption of home healthcare
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Lack of awareness in developing and under-developed regions
      • 3.2.2.2 Risks associated with enteral feeding
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Gap analysis
  • 3.6 Technology landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Nasoenteric/nasal feeding tube
    • 5.2.1 Nasogastric tube
    • 5.2.2 Nasojejunal tube
  • 5.3 Abdominal/ostomy feeding tube
    • 5.3.1 Gastrostomy tube
    • 5.3.2 Jejunostomy/jejunal tube
    • 5.3.3 Gastrojejunal (GJ) or transjejunal tube

Chapter 6 Market Estimates and Forecast, By Disease Condition, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cancer
    • 6.2.1 Head and neck cancer
    • 6.2.2 Gastrointestinal cancer
    • 6.2.3 Other cancers
  • 6.3 Central nervous system (CNS) and mental health
  • 6.4 Non-malignant gastrointestinal (GI) disorders
  • 6.5 Other disease conditions

Chapter 7 Market Estimates and Forecast, By Patient, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Adult
  • 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By Tube Type, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Short term feeding tube
  • 8.3 Long term feeding tube
  • 8.4 Temporary feeding tube

Chapter 9 Market Estimates and Forecast, By Tube Placement, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Without surgery
  • 9.3 Surgical placement
  • 9.4 Endoscopic placement

Chapter 10 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 Home care
  • 10.3 Hospitals
  • 10.4 Other end-users

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 11.1 Key trends
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Netherlands
    • 11.3.7 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 South Korea
    • 11.4.6 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 UAE
    • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 Abbott Laboratories
  • 12.2 Applied Medical Technology, Inc.
  • 12.3 Avanos Medical, Inc.
  • 12.4 B. Braun Melsungen AG
  • 12.5 Becton, Dickinson and Company
  • 12.6 Boston Scientific Corporation
  • 12.7 C.R. Bard, Inc.
  • 12.8 Cardinal Health
  • 12.9 CONMED Corporation
  • 12.10 Cook Medical
  • 12.11 Danone S.A.
  • 12.12 Fresenius Kabi AG
  • 12.13 Medline Industries, Inc.
  • 12.14 MOOG Inc.
  • 12.15 Vygon